A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Viatris Inc stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 2,842 shares of VTRS stock, worth $36,462. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,842
Previous 2,841 0.04%
Holding current value
$36,462
Previous $30,000 6.67%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $10 - $12
1 Added 0.04%
2,842 $32,000
Q1 2024

May 10, 2024

BUY
$11.27 - $13.53 $11 - $13
1 Added 0.04%
2,841 $33,000
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $333 - $412
38 Added 1.36%
2,840 $30,000
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $165 - $220
18 Added 0.65%
2,802 $26,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $3,252 - $4,311
373 Added 15.47%
2,784 $30,000
Q3 2022

Nov 08, 2022

BUY
$8.48 - $11.13 $152 - $200
18 Added 0.75%
2,411 $21,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $1,283 - $1,582
-129 Reduced 5.11%
2,393 $25,000
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $166 - $261
17 Added 0.68%
2,522 $27,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $519 - $631
43 Added 1.75%
2,505 $34,000
Q3 2021

Nov 10, 2021

BUY
$13.25 - $15.13 $132 - $151
10 Added 0.41%
2,462 $33,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $998 - $1,243
-77 Reduced 3.04%
2,452 $35,000
Q1 2021

May 11, 2021

BUY
$13.59 - $18.54 $30,101 - $41,066
2,215 Added 705.41%
2,529 $35,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $4,490 - $5,884
314 New
314 $6,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.